CI The Cigna Group Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Jul 30, 2026CI Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
CI Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 5 de Junho de 2007 | 3-for-1 | Para frente |
| 18 de Maio de 1998 | 3-for-1 | Para frente |
Sobre The Cigna Group Common Stock Visão geral da empresa da Wikipedia
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations).
Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them.
History
Cigna was formed by the 1982 merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (the parent corporation of Insurance Company of North America, the first stock insurance company in America). The company name, Cigna, is a mix of letters from the merging companies, CG and INA. Insurance Company of North America was formed in 1792, while CG was created in 1865 by a special act of the Governor of Connecticut. In October 1871, the great Chicago Fire burned for two days, destroyed 2,000 acres, and left 100,000 people in Illinois homeless. INA paid $650,000, one of only 51 insurance companies (out of a total of 202) to pay claims in full.
Cigna sold the majority of its life insurance operations to Lincoln National Corporation in 1997.
In October 2011, Cigna agreed to buy HealthSpring Inc. for $3.8 billion to jump-start its business selling Medicare plans from 46,000 Medicare Advantage members to almost 400,000 Medicare Advantage members. The payment would come from an issue of new equity to cover about 20 percent of the value, with the rest funded by additional cash and debt. In 2013, Cigna operated in 30 countries, had approximately 35,800 employees and managed around US$53.734 billion in assets.
In June 2015, U.S. health insurer Anthem Inc. announced that it would acquire Cigna for $47 billion in cash and stock. Anthem confirmed it had reached a deal to buy Cigna on July 24, 2015. On July 21, 2016, the US Justice Department filed an antitrust suit to block the proposed merger, and a District Court ruling on February 8, 2017, blocked the merger on anticompetitive grounds. That month, Cigna Corp. called off its $48 billion merger agreement with Anthem Inc., with Anthem stating it would "continue to enforce its rights under the merger agreement and remains committed to closing the transaction." After exhausting federal appeals of the antitrust merger block, the companies turned on each other in Delaware's Court of Chancery. The legal saga came to an end with an August 31, 2020 decision denying both companies claims for compensation from the other for the failed merger.
On March 7, 2018, it was announced that Cigna would acquire Express Scripts in a $67 billion deal and on August 24, 2018, the shareholders of Cigna and Express Scripts approved the deal.
In June 2020, Cigna formed a strategic alliance with Priority Health to make comprehensive health care coverage more affordable and accessible to Michigan employers and customers.
In September 2020, Cigna rebranded its health services portfolio under the name Evernorth, which included Express Scripts, Accredo, and eviCore.
In October 2020, it was announced that Cigna and Envision Healthcare had renewed their agreement to include Envision's clinicians as in-network providers for Cigna's members. In 2021, Molina Healthcare acquired Cigna's Medicaid contracts in Texas for US$60 million.
On February 13, 2023, Cigna renamed its holding company The Cigna Group, its health benefits provider business unit Cigna Healthcare, and its Evernorth business unit Evernorth Health Services.
In January 2024, the company agreed with the Health Care Service Corporation (HCSC) to sell Cigna Group's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses. The total value of the transaction is about $3.7 billion. The deal also included a four-year service agreement under which Evernorth Health Services, a subsidiary of the Cigna Group, will continue to provide pharmacy benefits to Medicare beneficiaries. The deal closed on March 19, 2025.
On 8 July 2025, HCSC announced that its newly acquired Cigna Medicare Advantage products will be renamed Healthspring, which was a dormant brand name acquired as part of HCSC deal with the Cigna Group. A logo and website for the newly revived Healthspring brand have already been launched by HCSC, which now owns Healthspring.
Cigna Global Health Benefits
Cigna Global Health Benefits is a business unit within Cigna. The company is headquartered in Wilmington, Delaware, close to Philadelphia. Additional Cigna Global Health Benefits operations are located in Visalia, California, and Greenock, Scotland and Shanghai, China and Antwerp, Belgium. Sales offices are located in North America, Europe, Asia and the Middle East.
Products and services
CGHB global health plans typically include medical, dental, behavioral, and disability coverage, as well as business travel and life insurance components. Expatriates are defined as employees of multinational companies who work outside their home country on short- or long-term international assignments. CGHB maintains its own, in-house international claims platform, and offers a network of physicians and hospitals for its members (including 550,000 in the U.S. and more than 141,000 outside the U.S.).
Public relations and lobbying
Cigna spent more than $4.4 million from 2005 to 2009 on lobbying to attain legislation that the company favors. This includes $720,000 spent in 2009 alone, when it had 20 lobbyists at five firms working on its behalf.
In 2008, the head of Cigna's public relations, Wendell Potter, resigned, becoming a whistleblower who gave testimony in 2009 to the U.S. Senate Committee on Commerce, Science and Transportation in favor of reform of the health care industry.
Controversies
Automatically rejecting claims with no review
In 2023, Cigna was criticized for allowing company doctors to reject claims even if they had not opened the patient's file. The company was found to be using a system, "PXDX," that, according to ProPublica, "saved money in two ways. It allowed Cigna to begin turning down claims that it had once paid. And it made it cheaper to turn down claims, because the company's doctors never had to open a file or conduct any in-depth review. They simply denied the claims in bulk with an electronic signature." The speed with which denials were placed was termed internally as "click and close."
Nataline Sarkisyan liver transplant case
In December 2007, Cigna refused to pay for a liver transplant of a California teenage girl, Nataline Sarkisyan, coming under scrutiny as a result. There was a liver ready and waiting to be transplanted, and doctors estimated she had a 65% chance of surviving at least six months. In response to much protest and public scrutiny, Cigna reversed its decision, though Ms. Sarkisyan died awaiting the transplant.
Even though liver transplants have been performed since 1963 and are a well-accepted treatment option for end-stage liver disease and acute liver failure, Cigna defended its actions by claiming that there was insufficient data to show that a transplant for a patient in Sarkisyan's condition would be safe and effective. The California court agreed with Cigna's position that the Sarkisyans’ claims regarding Cigna's decision-making were preempted by federal ERISA law. On April 16, 2009, the United States District Court for the Central District of California dismissed all of the claims against Cigna related to the coverage determination.
The UK newspaper The Guardian in their Esc and Ctrl videoblog about control of the Internet by corporations, documented the incident with Nataline Sarkisyan and the former vice president of Cigna talking about astroturfing, the practice of creating fake blogs by interested groups, e.g. health insurance companies, to push claims that are profitable for said company into media, e.g. dismissing universal health care.
Other controversies
In 2002, Cigna was alleged in violation of the Securities Exchange Act for earnings manipulation. Its common stock price plummeted significantly as a result.
In 2015, the American Consumer Satisfaction Index named Cigna as one of the most hated companies in the U.S. Cigna's name returned on the ACSI's most hated list in 2018.
In August 2020, the Department of Justice filed a lawsuit against Cigna alleging that the company defrauded Medicare Advantage, Medicare, and Medicaid for $1.4B by submitting diagnostic codes for health conditions that patients did not have.
In November 2020, investors sued Cigna's CEO and board, alleging that they had used "black-ops-style" tactics to "blow up" the potential merger with Anthem in 2017. One pension fund accused Cigna CEO David Cordani of seeking to poison the deal after he had failed to secure the top post in the resulting company. The fund claimed he had utilized lawyers and public relations specialists to set up a "Trojan Horse" campaign. The merger would have produced the largest U.S. health insurer in 2017.
Evaluations
Cigna received gold in the 2009 Gartner & 1to1 Customer Experience Excellence Award. The awards are given to the companies that "most clearly demonstrate exemplary customer relationship strategy and an unrivaled level of excellence in delivering the customer experience".
In January 2010, Cigna received the JD Power award for customer service for all of its call centers for the fourth time in a row.
In 2011, the California Nurses Association determined that Cigna denied roughly 39.6% of all claims (compared to competitors such as Aetna, who denied about 5.9% of all claims in the same time frame).
Strategic alliances
On April 16, 2010, Cigna announced an alliance with Humana group to offer a streamlined Medicare Advantage offering through employer clients for retirees. In November 2023, Reuters reported that Cigna and Humana were in talk to merge, in a deal totalling $60 billion. In December 2023, The Wall Street Journal reported that merger talks ended.
In November 2011, Cigna and TTK Group, an Indian business conglomerate focused on healthcare, formed a joint venture called Cigna TTK to develop a health insurance business in India, subject to obtaining government approvals.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | CI | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 11.2média 5A ≈16.5 | ≈16.5 | 23.3 | Subvalorizado | |
| P/S | 0.3média 5A ≈0.4 | ≈0.4 | 1.3 | Subvalorizado | |
| P/B | 1.7média 5A ≈1.9 | ≈1.9 | 2.9 | Subvalorizado | |
| EV / EBITDA | 5.2média 5A ≈6.5 | ≈6.5 | 11.4 | Subvalorizado | |
| Price / Cash Flow (Preço / Fluxo de Caixa) | 7.4média 5A ≈8.8 | ≈8.8 | 9.8 | Subvalorizado | |
| EV / Revenue (EV / Receita) | 0.2média 5A ≈0.4 | ≈0.4 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | CI | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | 3.5%média 5A ≈4.2% | ≈4.2% | 8.3% | Fraco | |
| Margem EBITDA (TTM) | 4.5%média 5A ≈5.5% | ≈5.5% | 8.8% | Fraco | |
| Margem de Impostos Pré-Tributação (TTM) | 3.1%média 5A ≈3.3% | ≈3.3% | 3.8% | Fraco | |
| Margem de Lucro Líquido (TTM) | 2.2%média 5A ≈2.7% | ≈2.7% | 5.1% | Fraco | |
| ROA (TTM) | 4.0%média 5A ≈3.6% | ≈3.6% | 4.0% | Em linha | |
| ROE (TTM) | 15.0%média 5A ≈12.1% | ≈12.1% | 12.5% | Em linha | |
| ROIC | 17.8%média 5A ≈15.9% | ≈15.9% | 9.2% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | CI | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 0.0média 5A ≈0.0 | ≈0.0 | 0.4 | Baixa dívida | |
| Índice de liquidez corrente (MRQ) | 0.8média 5A ≈0.8 | ≈0.8 | 1.4 | Baixa liquidez | |
| Índice de Liquidez Seca (MRQ) | 0.7média 5A ≈0.6 | ≈0.6 | 0.8 | Baixa liquidez |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | CI | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 11.2%média 5A ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 15.0%média 5A ≈11.4% | ≈11.4% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 11.4% | · | · | · | |
| EPS YoY | 83.0%média 5A ≈7.7% | ≈7.7% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | 73.5%média 5A ≈1.0% | ≈1.0% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 1.2%média 5A ≈-5.3% | ≈-5.3% | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | -0.69% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | -4.2%média 5A ≈-11.2% | ≈-11.2% | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | -6.8% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | CI | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 1.8média 5A ≈1.4 | ≈1.4 | 1.2 | Primeira linha | |
| Inventory Turnover (Giro de Estoque) | 30.6média 5A ≈29.9 | ≈29.9 | 15.6 | Primeira linha | |
| Receivables Turnover (Giro de Contas a Receber) | 10.4média 5A ≈11.5 | ≈11.5 | 10.5 | Em linha | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$4.2M | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor | Moeda | Rendimento |
|---|---|---|---|
| Set 8, 2026 | $1,56 | USD | ≈2.2% |
| Jun 4, 2026 | $1,56 | USD | ≈2.2% |
| Mar 5, 2026 | $1,56 | USD | ≈2.2% |
| Dez 4, 2025 | $1,51 | USD | ≈2.3% |
| Set 4, 2025 | $1,51 | USD | ≈2.0% |
| Jun 3, 2025 | $1,51 | USD | ≈1.9% |
| Mar 5, 2025 | $1,51 | USD | ≈1.8% |
| Dez 4, 2024 | $1,40 | USD | ≈1.7% |
| Set 4, 2024 | $1,40 | USD | ≈1.5% |
| Jun 4, 2024 | $1,40 | USD | ≈1.6% |
| Mar 5, 2024 | $1,40 | USD | ≈1.5% |
| Dez 5, 2023 | $1,23 | USD | ≈1.9% |
| Set 5, 2023 | $1,23 | USD | ≈1.7% |
| Jun 6, 2023 | $1,23 | USD | ≈1.8% |
| Mar 7, 2023 | $1,23 | USD | ≈1.6% |
| Dez 5, 2022 | $1,12 | USD | ≈1.4% |
| Set 6, 2022 | $1,12 | USD | ≈1.5% |
| Jun 7, 2022 | $1,12 | USD | ≈1.6% |
| Mar 8, 2022 | $1,12 | USD | ≈1.8% |
| Dez 6, 2021 | $1,00 | USD | ≈1.9% |
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Jul 29, 2026 | $7.78 | $7.83 | -0.59% |
| 31 de Março de 2026 | $7.79 | $7.84 | -0.65% | |
| 31 de Dezembro de 2025 | $8.08 | $8.11 | -0.41% | |
| 30 de Setembro de 2025 | $7.83 | $7.88 | -0.60% | |
| 30 de Junho de 2025 | $7.20 | $7.37 | -2.3% | |
| 31 de Março de 2025 | $6.74 | $6.54 | 3.0% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | $41.81B | $39.84B | |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B | $2.46B | $2.47B | |
| SG&A Expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B | $10.03B | $9.79B | |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B | |
| Other Non-op | $-1.41B | $-1.44B | $-1.45B | $-1.23B | $-1.21B | $-1.44B | $-1.68B | $-498M | $-252M | $-278M | |
| Pretax Income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B | $3.61B | $2.98B | |
| Income Tax | $1.49B | $1.49B | $141M | $1.61B | $1.37B | $2.38B | $1.45B | $935M | $1.37B | $1.14B | |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B | |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 | $8.92 | $7.31 | |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 | |
| Shares (Diluted) | 268,563,000 | 283,218,000 | 296,882,000 | 313,065,000 | 340,966,000 | 368,389,000 | 379,817,000 | 250,225,000 | 255,072,000 | 259,647,000 | |
| EBITDA | $11.97B | $12.19B | $11.57B | $11.35B | $10.86B | $10.96B | $11.73B | $4.86B | · | · |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B | $4.62B | $3.85B | $2.97B | $3.19B | |
| Short-term Investments | $1.06B | $665M | $925M | $905M | $920M | $1.33B | $937M | $2.04B | $2.14B | · | |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B | $12.19B | $10.72B | $10.47B | $3.15B | · | |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B | $3.17B | $2.66B | $2.82B | $228M | · | |
| Other Current Assets | $2.98B | $2.73B | $2.17B | $1.30B | $1.28B | $930M | $1.40B | $1.24B | $820M | · | |
| Current Assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | · | |
| PP&E (Net) | $3.65B | · | · | $3.77B | $3.69B | $4.21B | $4.42B | $4.56B | $1.56B | · | |
| PP&E (Gross) | $13.75B | · | · | $11.20B | $10.28B | $9.78B | $8.92B | $7.96B | $4.61B | · | |
| Accum. Depreciation | $10.10B | · | · | $7.43B | $6.59B | $5.58B | $4.50B | $3.40B | $3.05B | · | |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B | $44.65B | $44.60B | $44.51B | $6.16B | $5.98B | |
| Intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B | $35.18B | $36.56B | $39.00B | $345M | · | |
| Other Non-current Assets | $2.88B | $2.79B | $3.42B | $2.70B | $3.40B | $2.69B | $2.28B | $1.63B | $1.43B | · | |
| Total Assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Accounts Payable | $10.66B | $9.29B | $8.55B | $7.78B | $6.66B | $5.48B | $5.09B | $4.37B | $184M | · | |
| Short-term Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | $100M | · | |
| Current Liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B | $36.02B | $40.14B | $31.89B | $11.01B | · | |
| Capital Leases | · | · | $340M | $346M | · | $491M | $465M | · | · | · | |
| Deferred Tax | $7.14B | $6.97B | $7.17B | $7.79B | $8.35B | $8.94B | $9.39B | $9.45B | $0 | · | |
| Other Non-current Liabilities | $4.24B | $3.21B | $3.44B | $2.77B | $3.76B | $4.63B | $4.46B | $3.47B | $2.84B | · | |
| Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | · | |
| Long-term Debt | · | · | · | · | · | · | · | $39.52B | · | · | |
| Total Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | · | · | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $74M | · | |
| Retained Earnings | $47.87B | $43.52B | $41.65B | $37.94B | $32.59B | $28.57B | $20.16B | $15.09B | $15.80B | · | |
| Treasury Stock | $35.14B | $31.44B | $24.24B | $21.84B | $14.18B | $6.37B | $2.19B | $104M | $4.02B | · | |
| AOCI | $-2.81B | $-2.34B | $-1.86B | $-1.66B | $-884M | $-861M | $-941M | $-1.71B | $-1.08B | · | |
| Stockholders' Equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B | $50.32B | $45.34B | $41.03B | $13.71B | · | |
| Liabilities + Equity | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Shares Outstanding | 263,464,000 | 273,789,000 | 292,504,000 | 298,676,000 | 322,948,000 | 354,771,000 | 372,531,000 | 380,924,000 | 0 | 0 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695M | $566M | $610M | |
| Deferred Tax | $326M | $-95M | $-1.66B | $-472M | $-216M | $-386M | $-313M | $-101M | $242M | $74M | |
| Amort. of Intangibles | $1.74B | $1.70B | $1.82B | $1.88B | $2.00B | $1.98B | $2.95B | $235M | $115M | $151M | |
| Restructuring | · | $0 | $252M | $22M | $168M | · | · | · | · | · | |
| Other Non-cash | $543M | $3.90B | $5.07B | $-547M | $-927M | $-555M | $1.03B | $530M | · | · | |
| Operating Cash Flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B | |
| CapEx | · | · | · | · | · | · | $1.05B | $528M | $471M | $461M | |
| Investing Cash Flow | $-4.41B | $-2.10B | $-5.17B | $3.10B | $-3.61B | $2.98B | $-734M | $-26.38B | $-1.70B | $-2.57B | |
| Debt Issued | $4.46B | $4.46B | $1.49B | $0 | $4.26B | $3.46B | $0 | $22.86B | $1.58B | $0 | |
| Net Debt Issued | $261M | $1.46B | $-1.48B | $-500M | $-318M | $-4.58B | $-4.49B | $22.73B | · | · | |
| Stock Issued | $203M | $305M | $187M | $389M | $326M | $376M | $224M | $68M | $131M | $36M | |
| Stock Repurchased | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342M | $2.73B | $139M | |
| Net Stock Activity | $-3.42B | $-6.73B | $-2.10B | $-7.22B | $-7.42B | $-3.67B | $-1.76B | $-274M | · | · | |
| Dividends Paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · | |
| Financing Cash Flow | $-6.42B | $-7.65B | $-4.29B | $-11.24B | $-8.21B | $-8.53B | $-7.19B | $23.52B | $-2.65B | $-225M | |
| Net Change in Cash | $-1.20B | $594M | $2.36B | $428M | $-4.70B | $4.83B | $1.56B | $883M | $-213M | $1.22B | |
| Taxes Paid | $399M | $898M | $1.47B | $1.85B | $2.24B | $1.84B | $1.78B | $1.02B | $1.04B | $1.06B | |
| Free Cash Flow | · | · | · | · | · | · | $8.44B | $3.24B | · | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | · | · | |
| Net Margin | 2.2% | 1.5% | 2.8% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | · | · | |
| Pretax Margin | 2.8% | 2.1% | 2.8% | 4.6% | 3.9% | 6.8% | 4.3% | 7.4% | · | · | |
| EBITDA Margin | 4.4% | 4.9% | 5.9% | 6.3% | 6.2% | 6.8% | 7.6% | 10.0% | · | · | |
| ROA | 3.8% | 2.5% | 3.6% | 4.5% | 3.5% | 5.5% | 3.3% | 2.5% | · | · | |
| ROE | 14.4% | 8.7% | 11.8% | 14.7% | 11.1% | 17.8% | 11.9% | 9.7% | · | · | |
| ROIC | 17.8% | 16.1% | 17.5% | 15.1% | 12.9% | 12.4% | 13.6% | 7.2% | · | · |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | · | · | |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | · | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.6 | 1.3 | 1.2 | 1.1 | 1.0 | 1.0 | 0.5 | · | · | |
| Inventory Turnover | 30.6 | 29.6 | 25.7 | 29.4 | 34.1 | 35.5 | 35.6 | 3.1 | · | · | |
| Receivables Turnover | 10.4 | 11.8 | 11.2 | 11.2 | 12.8 | 14.0 | 14.5 | 7.1 | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $158.33 | $149.87 | $158.03 | $150.24 | $145.88 | $141.84 | $121.70 | $107.71 | · | · | |
| Revenue / Share | $1023.60 | $872.55 | $657.72 | $576.61 | $510.54 | $435.41 | $404.32 | $194.43 | · | · | |
| Cash Flow / Share | $35.75 | $36.59 | $39.79 | $27.65 | $21.09 | $28.10 | $24.97 | $15.07 | · | · | |
| Cash / Share | $29.13 | $27.58 | $26.74 | $19.83 | $15.73 | $28.70 | $12.40 | $10.12 | · | · | |
| Dividend / Share | $6.04 | $5.60 | $4.92 | $4.48 | $4.00 | $0.04 | $0.04 | $0.04 | $0.04 | · | |
| EPS (TTM) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.2% | 26.6% | 8.2% | 3.7% | 8.5% | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.0% | 12.4% | 6.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 83.0% | -30.3% | -18.8% | 35.9% | -31.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 1.2% | -8.4% | -8.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -0.69% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 73.5% | -33.5% | -23.9% | 25.1% | -36.1% | · | · | · | · | · | |
| Net Income CAGR 3Y | -4.2% | -14.1% | -15.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.8% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 154.8% | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | · | · | |
| Net Income TTM | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | · | · | |
| Market Cap | $72.51B | $75.60B | $87.59B | $98.96B | $74.16B | $73.86B | $76.18B | $72.35B | · | · | |
| Enterprise Value | $63.78B | $68.27B | $80.08B | $92.13B | $70.18B | $63.37B | $71.57B | $67.95B | · | · | |
| P/E | 12.4 | 22.8 | 17.2 | 15.5 | 14.6 | 9.1 | 15.2 | 18.0 | · | · | |
| P/S | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 1.5 | · | · | |
| P/B | 1.7 | 1.8 | 1.9 | 2.2 | 1.6 | 1.5 | 1.7 | 1.8 | · | · | |
| P / Cash Flow | 7.6 | 7.3 | 7.4 | 11.4 | 10.3 | 7.1 | 8.0 | 19.2 | · | · | |
| P / FCF | · | · | · | · | · | · | 9.0 | 22.3 | · | · | |
| EV / EBITDA | 5.3 | 5.6 | 6.9 | 8.1 | 6.5 | 5.8 | 6.1 | 14.0 | · | · | |
| EV / FCF | · | · | · | · | · | · | 8.5 | 21.0 | · | · | |
| EV / Revenue | 0.2 | 0.3 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 1.4 | · | · | |
| Dividend Yield | 2.2% | 2.1% | 1.7% | 1.4% | 1.8% | 0.02% | 0.02% | · | · | · | |
| Earnings Yield | 8.1% | 4.4% | 5.8% | 6.5% | 6.9% | 11.0% | 6.6% | 5.5% | · | · | |
| Payout Ratio | 27.0% | 41.5% | 27.0% | 20.5% | 24.8% | · | · | · | · | · | |
| Annual Payout | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B | $51.11B | $49.05B | $48.59B | $46.52B | $45.75B | $45.28B | |
| Cost of Revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B | $35.26B | $33.64B | $33.44B | $31.46B | $32.09B | $31.78B | |
| SG&A Expense | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B | $3.59B | $3.68B | $3.71B | $4.06B | $3.79B | $3.43B | $3.54B | $3.48B | $3.15B | |
| Operating Income | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B | $2.06B | $2.24B | $2.22B | $2.02B | $1.75B | $2.14B | |
| Other Non-op | $-356M | $-357M | $-362M | $-347M | $-337M | $-362M | $-362M | $-376M | $-375M | $-322M | $-360M | $-365M | $-363M | $-358M | $-324M | $-304M | |
| Pretax Income | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79M | $188M | $1.84B | $1.88B | $1.60B | $1.36B | $3.49B | |
| Income Tax | $382M | $409M | $543M | $322M | $389M | $239M | $473M | $367M | $360M | $291M | $-919M | $391M | $374M | $295M | $136M | $713M | |
| Net Income | $1.66B | $1.65B | $943M | $1.97B | $1.53B | $1.32B | $1.19B | $825M | $1.63B | $-212M | $899M | $1.45B | $1.51B | $1.31B | $1.22B | $2.78B | |
| EPS (Basic) | $6.31 | $6.30 | $4.67 | $7.02 | $5.76 | $4.88 | $5.06 | $2.65 | $5.51 | $-0.97 | $3.54 | $4.79 | $4.96 | $4.28 | $3.89 | $9.07 | |
| EPS (Diluted) | $6.29 | $6.26 | $4.64 | $6.98 | $5.71 | $4.85 | $5.01 | $2.63 | $5.45 | $-0.97 | $3.49 | $4.74 | $4.92 | $4.24 | $3.82 | $8.97 | |
| Shares (Diluted) | 263,962,000 | 264,017,000 | · | 267,530,000 | 268,154,000 | 272,953,000 | · | 281,396,000 | 284,052,000 | 286,465,000 | · | 297,131,000 | 296,879,000 | 298,999,000 | · | 307,517,000 | |
| EBITDA | $3.33B | $3.01B | · | $3.27B | $2.99B | $2.65B | · | $2.58B | $2.41B | $3.00B | · | $2.24B | $2.22B | $2.76B | · | $2.14B |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | · | $8.50B | $9.59B | $7.93B | · | $7.08B | |
| Short-term Investments | $959M | $812M | $1.06B | $883M | $813M | $727M | $665M | $864M | $1.07B | $1.11B | · | $1.05B | $872M | $914M | · | $783M | |
| Receivables | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B | · | $19.08B | $18.33B | $17.70B | · | $17.27B | |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B | · | $4.42B | $4.51B | $4.21B | · | $4.02B | |
| Other Current Assets | $3.09B | $2.74B | $2.98B | $2.49B | $2.47B | $2.39B | $2.73B | $2.67B | $2.66B | $2.26B | · | $1.48B | $1.41B | $1.26B | · | $1.02B | |
| Current Assets | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B | $43.36B | · | $34.52B | $34.71B | $32.03B | · | $30.17B | |
| PP&E (Net) | · | · | $3.65B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $13.75B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B | $44.26B | $45.81B | $45.81B | $45.81B | $45.81B | $45.81B | |
| Intangibles | $26.93B | $27.32B | $28.56B | $28.98B | $28.67B | $29.05B | $29.42B | $29.79B | $30.18B | $30.49B | · | $31.32B | $31.71B | $32.10B | · | $32.88B | |
| Other Non-current Assets | $3.32B | $3.25B | $2.88B | $3.39B | $2.93B | $3.00B | $2.79B | $3.18B | $3.28B | $3.29B | · | $3.15B | $2.50B | $2.56B | · | $2.48B | |
| Total Assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Accounts Payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B | · | $7.67B | $8.07B | $7.36B | · | $6.87B | |
| Short-term Debt | $1.00B | · | $0 | · | · | $0 | $880M | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Current Liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B | · | $47.06B | $47.34B | $44.73B | · | $41.12B | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $368M | |
| Deferred Tax | $6.73B | $6.85B | $7.14B | $7.00B | $6.78B | $6.88B | $6.97B | $6.79B | $6.95B | $7.03B | · | $7.48B | $7.59B | $7.71B | · | $7.78B | |
| Other Non-current Liabilities | $5.61B | $4.77B | $4.24B | $3.87B | $3.65B | $3.58B | $3.21B | $3.03B | $3.54B | $3.65B | · | $2.93B | $2.58B | $2.69B | · | $3.18B | |
| Total Liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | · | $103.88B | $104.53B | $103.38B | · | $99.08B | |
| Total Debt | $1.00B | · | · | · | · | $0 | · | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Retained Earnings | $50.35B | $49.11B | $47.87B | $47.03B | $45.56B | $44.43B | $43.52B | $42.48B | $42.13B | $40.98B | · | $40.98B | $39.94B | $38.84B | · | $37.04B | |
| Treasury Stock | $35.47B | $35.22B | $35.14B | $34.13B | $34.13B | $33.06B | $31.44B | $29.41B | $29.41B | $27.77B | · | $23.74B | $23.05B | $22.91B | · | $19.39B | |
| AOCI | $-4.36B | $-3.60B | $-2.81B | $-2.80B | $-2.82B | $-2.59B | $-2.34B | $-2.16B | $-2.44B | $-2.32B | · | $-2.12B | $-1.88B | $-1.77B | · | $-2.01B | |
| Stockholders' Equity | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | · | $45.69B | $45.45B | $44.50B | · | $45.04B | |
| Liabilities + Equity | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Shares Outstanding | · | · | 263,464,000 | · | · | · | 273,789,000 | · | · | · | 292,504,000 | · | · | · | 298,676,000 | · |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $655M | $650M | $722M | $697M | $682M | $674M | $646M | $650M | $738M | $741M | $765M | $766M | $755M | $749M | $735M | $726M | |
| Amort. of Intangibles | $389M | $390M | $463M | $436M | $422M | $422M | $424M | $436M | $420M | $423M | $451M | $454M | $455M | $459M | $457M | $460M | |
| Restructuring | · | · | · | $222M | $129M | $215M | · | $0 | $0 | $0 | $252M | $0 | $0 | · | $0 | $0 | |
| Other Non-cash | · | $-1.17B | · | · | · | $-163M | · | · | · | $4.31B | · | · | · | $2.97B | · | · | |
| Operating Cash Flow | $-421M | $1.13B | $6.15B | $3.42B | $-1.89B | $1.92B | $5.21B | $46M | $265M | $4.84B | $1.47B | $2.83B | $2.49B | $5.03B | $2.10B | $3.28B | |
| Investing Cash Flow | $-503M | $-637M | $-420M | $-4.39B | $-797M | $1.20B | $-191M | $-776M | $-640M | $-495M | $-440M | $-1.34B | $-414M | $-2.98B | $-616M | $4.45B | |
| Debt Issued | · | · | $-3M | $4.46B | $0 | $0 | $0 | $0 | $0 | $4.46B | $0 | $0 | $0 | $1.49B | $0 | $0 | |
| Net Debt Issued | · | $-550M | · | · | · | $-700M | · | · | · | $2.25B | · | · | · | $1.41B | · | · | |
| Stock Issued | $101M | $57M | $25M | $37M | $72M | $69M | $22M | $62M | $40M | $181M | $74M | $54M | $29M | $30M | $72M | $100M | |
| Stock Repurchased | $280M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990M | $4.02B | $544M | $624M | $154M | $962M | $1.73B | $3.50B | |
| Net Stock Activity | · | $57M | · | · | · | $-1.44B | · | · | · | $-3.84B | · | · | · | $-932M | · | · | |
| Dividends Paid | $409M | $417M | $396M | $402M | $401M | $412M | $384M | $390M | $392M | $401M | $358M | $362M | $362M | $368M | $334M | $341M | |
| Financing Cash Flow | $207M | $-1.14B | $-4.07B | $2.66B | $-1.33B | $-3.68B | $-3.25B | $439M | $-2.31B | $-2.53B | $-1.25B | $-2.57B | $-435M | $-37M | $-2.64B | $-5.52B | |
| Net Change in Cash | $-724M | $-656M | $1.67B | $1.69B | $-3.99B | $-555M | $1.75B | $-273M | $-2.69B | $1.81B | $-209M | $-1.09B | $1.65B | $2.01B | $-1.14B | $2.19B | |
| Taxes Paid | · | · | $43M | $6M | $210M | $140M | $59M | $272M | $457M | $110M | $91M | $454M | $849M | $77M | $504M | $435M |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.7% | 3.4% | · | 3.7% | 3.4% | 3.0% | · | 4.0% | 4.0% | 3.9% | · | 4.6% | 4.6% | 4.3% | · | 4.7% | |
| Net Margin | 2.3% | 2.4% | · | 2.8% | 2.4% | 2.1% | · | 1.3% | 2.7% | -0.37% | · | 2.9% | 3.1% | 2.8% | · | 6.1% | |
| Pretax Margin | 3.1% | 3.3% | · | 3.3% | 3.0% | 2.5% | · | 1.9% | 3.3% | 0.14% | · | 3.8% | 3.9% | 3.4% | · | 7.7% | |
| EBITDA Margin | 4.7% | 4.4% | · | 4.7% | 4.5% | 4.0% | · | 4.0% | 4.0% | 5.2% | · | 4.6% | 4.6% | 5.9% | · | 4.7% | |
| ROA | 1.1% | 1.1% | · | 1.2% | 1.1% | 0.93% | · | 0.54% | 1.1% | -0.14% | · | 0.99% | 1.0% | 0.87% | · | 1.9% | |
| ROE | 4.0% | 4.0% | · | 4.7% | 4.0% | 3.5% | · | 1.9% | 3.8% | -0.49% | · | 3.2% | 3.3% | 2.9% | · | 6.0% | |
| ROIC | 5.1% | 4.6% | · | 5.3% | 4.6% | 4.2% | · | 4.1% | 4.7% | -14.4% | · | 3.7% | 3.9% | 3.7% | · | 3.8% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Quick Ratio | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.0 | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 9.6 | 9.8 | · | 10.4 | 9.6 | 9.9 | · | 10.0 | 9.2 | 9.4 | · | 8.0 | 8.1 | 8.2 | · | 9.0 | |
| Receivables Turnover | 2.3 | 2.6 | · | 2.3 | 2.4 | 2.8 | · | 2.7 | 2.8 | 3.0 | · | 2.7 | 2.7 | 2.8 | · | 2.7 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $271.51 | $259.43 | · | $260.71 | $250.52 | $239.98 | · | $226.35 | $213.07 | $199.87 | · | $165.07 | $163.66 | $155.58 | · | $147.24 | |
| Cash Flow / Share | · | $4.28 | · | · | · | $7.03 | · | · | · | $16.90 | · | · | · | $16.82 | · | · | |
| Dividend / Share | $1.56 | $1.56 | $1.51 | $1.51 | $1.51 | $1.51 | $1.40 | $1.40 | $1.40 | $1.40 | $1.23 | $1.23 | $1.23 | $1.23 | $1.12 | $1.12 | |
| EPS (TTM) | $24.17 | $23.59 | · | $22.55 | $18.20 | $17.94 | · | $10.60 | $12.71 | $12.18 | · | $17.72 | $21.95 | $21.92 | · | $20.99 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $282.38B | $277.89B | · | $268.08B | $262.02B | $255.37B | · | $232.59B | $217.94B | $206.00B | · | $189.90B | $186.14B | $183.03B | · | $180.44B | |
| Net Income TTM | $6.23B | $6.10B | · | $6.02B | $4.87B | $4.97B | · | $3.14B | $3.77B | $3.65B | · | $5.49B | $6.82B | $6.88B | · | $6.70B | |
| P/E | 11.4 | 11.3 | · | 12.8 | 18.2 | 18.3 | · | 32.7 | 26.0 | 29.8 | · | 16.1 | 12.8 | 11.7 | · | 13.2 | |
| Earnings Yield | 8.8% | 8.8% | · | 7.8% | 5.5% | 5.5% | · | 3.1% | 3.8% | 3.4% | · | 6.2% | 7.8% | 8.6% | · | 7.6% | |
| Payout Ratio | · | 25.2% | · | · | · | 29.2% | · | · | · | -189.2% | · | · | · | 28.2% | · | · | |
| Annual Payout | $1.62B | $1.62B | · | $1.60B | $1.59B | $1.58B | · | $1.54B | $1.51B | $1.48B | · | $1.43B | $1.41B | $1.40B | · | $1.37B |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Margem Operacional % | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% |
| Lucro líquido | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| EPS Diluído | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Índice de liquidez corrente | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 |
| Índice de Liquidez Seca | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 |
Ainda não há dados fundamentais suficientes para construir esta demonstração.
Investidores institucionais (13F) 1.867 declarantes · $73.0B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 160 (-31 vs trimestre anterior) | 92 (-24 vs trimestre anterior) | 684 (+29 vs trimestre anterior) | 593 (+10 vs trimestre anterior) | +5.4M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $7.203.753.597 | 26.173.577 | 9,87% | Ações |
| BlackRock, Inc. | $6.461.456.854 | 23.438.250 | 8,85% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.762.729.281 | 17.276.296 | 6,53% | Ações |
| STATE STREET CORP | $3.496.245.161 | 12.682.259 | 4,79% | Ações |
| Dodge & Cox | $3.356.093.871 | 12.173.875 | 4,60% | Ações |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $2.895.610.431 | 10.443.691 | 3,97% | Ações |
| Sanders Capital, LLC | $2.796.668.015 | 10.144.617 | 3,83% | Ações |
| FMR LLC | $2.210.454.198 | 8.018.189 | 3,03% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.720.317.832 | 6.268.347 | 2,36% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.717.104.307 | 6.228.614 | 2,35% | Ações |
| GQG Partners LLC | $1.628.918.123 | 5.908.707 | 2,23% | Ações |
| JPMORGAN CHASE & CO | $1.447.877.312 | 5.194.363 | 1,98% | Ações |
| MORGAN STANLEY | $1.017.483.597 | 3.690.812 | 1,39% | Ações |
| NORGES BANK | $982.164.860 | 3.562.699 | 1,35% | Ações |
| BANK OF AMERICA CORP /DE/ | $827.692.197 | 3.002.366 | 1,13% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $785.495.575 | 2.849.302 | 1,08% | Ações |
| NORTHERN TRUST CORP | $752.795.794 | 2.730.687 | 1,03% | Ações |
| AMERIPRISE FINANCIAL INC | $719.183.166 | 2.608.447 | 0,99% | Ações |
| Grantham, Mayo, Van Otterloo & Co. LLC | $710.448.797 | 2.577.075 | 0,97% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $692.582.460 | 2.512.025 | 0,95% | Ações |
| Invesco Ltd. | $662.627.873 | 2.403.612 | 0,91% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $656.057.221 | 2.459.446 | 0,90% | Ações |
| Davis Selected Advisers | $621.243.564 | 2.253.424 | 0,85% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $600.668.400 | 2.178.861 | 0,82% | Ações |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $558.018.223 | 2.024.152 | 0,76% | Ações |
| Boston Partners | $555.607.176 | 2.014.660 | 0,76% | Ações |
| GOLDMAN SACHS GROUP INC | $548.715.710 | 1.990.408 | 0,75% | Ações |
| Legal & General Group Plc | $542.779.462 | 1.968.875 | 0,74% | Ações |
| TWO SIGMA INVESTMENTS, LP | $499.838.165 | 1.813.110 | 0,68% | Ações |
| Amundi | $472.966.222 | 1.715.636 | 0,65% | Ações |
| Bank of New York Mellon Corp | $450.936.717 | 1.635.725 | 0,62% | Ações |
| NORDEA INVESTMENT MANAGEMENT AB | $409.669.412 | 1.476.499 | 0,56% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $409.373.497 | 1.484.959 | 0,56% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $396.029.634 | 1.436.556 | 0,54% | Ações |
| NATIONAL BANK OF CANADA /FI/ | $396.005.041 | 1.436.453 | 0,54% | Ações |
| Nuveen, LLC | $372.070.579 | 1.349.647 | 0,51% | Ações |
| Capital World Investors | $365.436.721 | 1.325.583 | 0,50% | Ações |
| DEUTSCHE BANK AG\ | $352.569.909 | 1.278.910 | 0,48% | Ações |
| Capital Research Global Investors | $340.312.625 | 1.234.448 | 0,47% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $297.765.000 | 1.080.111 | 0,41% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $295.639.232 | 1.072.400 | 0,41% | Opção de compra |
| RAYMOND JAMES FINANCIAL INC | $285.021.252 | 1.033.884 | 0,39% | Ações |
| BloombergSen Inc. | $250.400.144 | 908.300 | 0,34% | Opção de compra |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $241.311.801 | 875.333 | 0,33% | Ações |
| Russell Investments Group, Ltd. | $233.022.643 | 844.481 | 0,32% | Ações |
| BRANDES INVESTMENT PARTNERS, LP | $232.489.133 | 843.317 | 0,32% | Ações |
| National Pension Service | $218.948.088 | 794.211 | 0,30% | Ações |
| UBS Group AG | $213.774.402 | 775.444 | 0,29% | Ações |
| Sumitomo Mitsui Trust Group, Inc. | $210.159.410 | 762.331 | 0,29% | Ações |
| Swiss National Bank | $205.012.464 | 743.661 | 0,28% | Ações |
Executivos da empresa 41 insiders · 8 diretores · 11 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Everett Neville | EVP, Special Advisor to the CEO | 3 de Setembro de 2026 S | 5.053 | 0 | 2 | $-671.895 |
| Brian C Evanko | President and Chief Executive Officer | 1 de Setembro de 2026 A | 41.030 | 0 | 1 | $-1.610.400 |
| David Cordani | Chairman & CEO | 13 de Maio de 2026 M | 57.766 | 1 | 13 | $-58.114.037 |
| Ann M Dennison | EVP, CFO | 27 de Fevereiro de 2026 A | 7.745 | 0 | 0 | $0 |
| Nicole S Jones | EVP, Chief Administrative Officer and Chief Human Resources Officer | 18 de Agosto de 2026 S | 25.880 | 0 | 3 | $-6.784.615 |
| Bryan Holgerson | Title - President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes | 6 de Agosto de 2026 A | · | 0 | 0 | $0 |
| Jamie G Kates | Chief Accounting Officer | 12 de Junho de 2026 M | 2.368 | 0 | 1 | $-268.450 |
| Durga Prasad Koka | EVP, Global CIO | 1 de Junho de 2026 F | 6.552 | 0 | 0 | $0 |
| George Kurian | Conselheiro | 31 de Agosto de 2026 A | 4.560 | 0 | 0 | $0 |
| Neesha Hathi | Conselheiro | 22 de Abril de 2026 A | 4.151 | 0 | 0 | $0 |
| Philip Ozuah | Conselheiro | 22 de Abril de 2026 A | 2.583 | 0 | 0 | $0 |
| Mark B. Mcclellan | Conselheiro | 22 de Abril de 2026 A | 6.891 | 0 | 0 | $0 |
| Kimberly A. Ross | Conselheiro | 22 de Abril de 2026 A | 5.294 | 0 | 0 | $0 |
| Michael J Hennigan | Conselheiro | 22 de Abril de 2026 A | 1.350 | 0 | 0 | $0 |
| Kathleen M Mazzarella | Conselheiro | 22 de Abril de 2026 A | 6.891 | 0 | 0 | $0 |
| Donna F Zarcone | Conselheiro | 22 de Abril de 2026 A | 27.517 | 0 | 0 | $0 |
| Eric C Wiseman | Conselheiro | 22 de Abril de 2026 A | 23.940 | 0 | 0 | $0 |
| Eric J Foss | Conselheiro | 22 de Abril de 2026 A | 36.696 | 0 | 0 | $0 |
| David J Brailer | · | 29 de Agosto de 2025 F | 17.525 | 0 | 0 | $0 |
| Elder Granger | · | 23 de Abril de 2025 A | 6.109 | 0 | 0 | $0 |
| Noelle K Eder | · | 7 de Março de 2025 S | 13.406 | 0 | 0 | $0 |
| Eric P Palmer | · | 28 de Fevereiro de 2025 A | 66.160 | 0 | 0 | $0 |
| William J Delaney III | · | 19 de Agosto de 2024 M | 17.539 | 0 | 0 | $0 |
| Michael W Triplett | · | 12 de Agosto de 2024 M | 32.833 | 0 | 0 | $0 |
| Mary T Hoeltzel | · | 14 de Maio de 2024 M | 2.595 | 0 | 0 | $0 |
| Cynthia Ryan | · | 30 de Agosto de 2023 M | 5.937 | 0 | 0 | $0 |
| Paul A Sanford | · | 19 de Julho de 2023 S | 8.679 | 0 | 0 | $0 |
| Jason D Sadler | · | 24 de Fevereiro de 2023 A | 47.015 | 0 | 0 | $0 |
| Charles Berg | · | 8 de Fevereiro de 2023 G | · | 0 | 0 | $0 |
| John Partridge | · | 26 de Abril de 2022 A | 28.177 | 0 | 0 | $0 |
| MURABITO JOHN M | · | 1 de Março de 2022 F | 51.226 | 0 | 0 | $0 |
| HARRIS ISAIAH JR | · | 30 de Novembro de 2021 A | 20.015 | 0 | 0 | $0 |
| Matthew G Manders | · | 19 de Novembro de 2021 F | 43.488 | 0 | 0 | $0 |
| Timothy C Wentworth | · | 12 de Maio de 2021 G | 29.783 | 0 | 0 | $0 |
| Kristen Lauria | · | 30 de Abril de 2021 F | 2.785 | 0 | 0 | $0 |
| Steven B Miller | · | 26 de Fevereiro de 2021 F | 28.439 | 0 | 0 | $0 |
| William L Roper | · | 26 de Fevereiro de 2021 A | 8.583 | 0 | 0 | $0 |
| Roman Martinez IV | · | 30 de Novembro de 2020 A | 48.839 | 0 | 0 | $0 |
| Mark L Boxer | · | 28 de Fevereiro de 2020 F | 49.191 | 0 | 0 | $0 |
| ZOLLARS WILLIAM D | · | 13 de Setembro de 2019 S | 13.500 | 0 | 0 | $0 |
| Lisa R Bacus | · | 1 de Março de 2019 F | 24.024 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 156 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IHF · iShares Trust | 4,00% | 186.760 SH | 11 de Setembro de 2026 | Diário |
| DUSA · Davis Fundamental ETF Trust | 3,12% | 142.104 NS | 31 de Julho de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,29% | 86.083 NS | 31 de Julho de 2026 | N-PORT |
| SMRI · EA Series Trust | 1,79% | 41.365 NS | 31 de Julho de 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1,73% | 6.426 SH | 2 de Outubro de 2026 | Diário |
| RPV · Invesco Exchange-Traded Fund Trust | 1,61% | 100.414 SH | 2 de Outubro de 2026 | Diário |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,59% | 51.721 SH | 2 de Outubro de 2026 | Diário |
| PWV · Invesco Exchange-Traded Fund Trust | 1,46% | 99.278 SH | 2 de Outubro de 2026 | Diário |
| NUDV · Nushares ETF Trust | 1,45% | 2.607 NS | 31 de Julho de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,40% | 505.789 SH | 2 de Outubro de 2026 | Diário |
| DWLD · Davis Fundamental ETF Trust | 1,36% | 29.890 NS | 31 de Julho de 2026 | N-PORT |
| IYH · iShares Trust | 1,18% | 152.840 SH | 11 de Setembro de 2026 | Diário |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,17% | 89.096 SH | 2 de Outubro de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 1,07% | 792.582 SH | 19 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 1,06% | 125.422 NS | 31 de Julho de 2026 | N-PORT |
| IMCV · iShares Trust | 1,00% | 41.404 SH | 11 de Setembro de 2026 | Diário |
| FFLV · FIDELITY COVINGTON TRUST | 0,97% | 573 NS | 31 de Julho de 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,95% | 11.306 NS | 31 de Julho de 2026 | N-PORT |
| IXJ · iShares Trust | 0,94% | 139.115 SH | 11 de Setembro de 2026 | Diário |
| RILA · Spinnaker ETF Series | 0,93% | 1.412 NS | 31 de Julho de 2026 | N-PORT |
| VLUE · iShares Trust | 0,90% | 308.315 SH | 11 de Setembro de 2026 | Diário |
| FBCV · FIDELITY COVINGTON TRUST | 0,88% | 5.567 NS | 31 de Julho de 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,88% | 30.767.177 | 1 de Outubro de 2026 | Diário |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,87% | 43.607 NS | 31 de Julho de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,85% | 5.205 NS | 31 de Julho de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,80% | 24.655 SH | 19 de Agosto de 2026 | Diário |
| EQIN · Columbia ETF Trust I | 0,77% | 8.375 NS | 31 de Julho de 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,72% | 56.688 NS | 31 de Julho de 2026 | N-PORT |
| CVY · Invesco Exchange-Traded Fund Trust | 0,68% | 2.953 SH | 2 de Outubro de 2026 | Diário |
| DFLV · Dimensional ETF Trust | 0,63% | 152.491 NS | 31 de Julho de 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,61% | 128.339 NS | 31 de Julho de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,61% | 22.064 SH | 2 de Outubro de 2026 | Diário |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,61% | 17.898.000 | 2 de Outubro de 2026 | Diário |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,57% | 150.000 | 2 de Outubro de 2026 | Diário |
| FFLC · FIDELITY COVINGTON TRUST | 0,56% | 24.069 NS | 31 de Julho de 2026 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 0,55% | 28.136 NS | 31 de Julho de 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,55% | 2.200 NS | 31 de Julho de 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,53% | 1.744 NS | 31 de Julho de 2026 | N-PORT |
| IMCB · iShares Trust | 0,50% | 29.774 SH | 11 de Setembro de 2026 | Diário |
| QLC · FlexShares Trust | 0,48% | 17.472 NS | 31 de Julho de 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,48% | 664 NS | 31 de Julho de 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,46% | 25.557 NS | 31 de Julho de 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,44% | 2.633 NS | 31 de Julho de 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,43% | 560.000 | 2 de Outubro de 2026 | Diário |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,43% | 19.669.000 | 2 de Outubro de 2026 | Diário |
| XOEF · iShares Trust | 0,42% | 331 SH | 11 de Setembro de 2026 | Diário |
| DFUV · Dimensional ETF Trust | 0,37% | 206.037 NS | 31 de Julho de 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,37% | 1.294 NS | 31 de Julho de 2026 | N-PORT |
| ESMV · iShares Trust | 0,37% | 102 SH | 11 de Setembro de 2026 | Diário |
| CATH · Global X Funds | 0,35% | 16.346 NS | 31 de Julho de 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,34% | 166.268 SH | 19 de Agosto de 2026 | Diário |
| DGRO · iShares Trust | 0,33% | 509.486 SH | 11 de Setembro de 2026 | Diário |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 9.701 NS | 31 de Julho de 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 52.531 NS | 31 de Julho de 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,30% | 111.655 SH | 2 de Outubro de 2026 | Diário |
| VYM · VANGUARD WHITEHALL FUNDS | 0,30% | 1.042.139 SH | 19 de Agosto de 2026 | Diário |
| EVUS · iShares Trust | 0,30% | 4.037 SH | 11 de Setembro de 2026 | Diário |
| DFVX · Dimensional ETF Trust | 0,28% | 5.359 NS | 31 de Julho de 2026 | N-PORT |
| IWX · iShares Trust | 0,27% | 37.789 SH | 11 de Setembro de 2026 | Diário |
| VTV · VANGUARD INDEX FUNDS | 0,27% | 2.516.218 SH | 19 de Agosto de 2026 | Diário |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 4.203 NS | 31 de Julho de 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,25% | 60.916 SH | 19 de Agosto de 2026 | Diário |
| IVE · iShares Trust | 0,25% | 438.897 SH | 11 de Setembro de 2026 | Diário |
| DFSU · Dimensional ETF Trust | 0,25% | 20.149 NS | 31 de Julho de 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,24% | 1.532 NS | 31 de Julho de 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,24% | 6.130 SH | 19 de Agosto de 2026 | Diário |
| IUSV · iShares Trust | 0,24% | 231.763 SH | 11 de Setembro de 2026 | Diário |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,23% | 6.639.000 | 2 de Outubro de 2026 | Diário |
| CHRI · Global X Funds | 0,22% | 64 NS | 31 de Julho de 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,22% | 2.603 NS | 31 de Julho de 2026 | N-PORT |
| SUSL · iShares Trust | 0,22% | 9.336 SH | 11 de Setembro de 2026 | Diário |
| ACVF · ETF Opportunities Trust | 0,21% | 1.165 NS | 31 de Julho de 2026 | N-PORT |
| DSI · iShares Trust | 0,21% | 40.359 SH | 11 de Setembro de 2026 | Diário |
| ILCV · iShares Trust | 0,21% | 9.900 SH | 11 de Setembro de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,21% | 4.094 NS | 31 de Julho de 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,21% | 14.065 SH | 11 de Setembro de 2026 | Diário |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,20% | 157.624 SH | 19 de Agosto de 2026 | Diário |
| IWD · iShares Trust | 0,20% | 580.231 SH | 11 de Setembro de 2026 | Diário |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 701.739 SH | 2 de Outubro de 2026 | Diário |
| ACWV · iShares, Inc. | 0,19% | 23.190 SH | 11 de Setembro de 2026 | Diário |
| ESGU · iShares Trust | 0,19% | 122.944 SH | 11 de Setembro de 2026 | Diário |
| ROUS · Lattice Strategies Trust | 0,19% | 4.742 NS | 31 de Julho de 2026 | N-PORT |
| MPLY · Strategy Shares | 0,18% | 104 NS | 31 de Julho de 2026 | N-PORT |
| SIZE · iShares Trust | 0,18% | 2.691 SH | 11 de Setembro de 2026 | Diário |
| GLBL · Pacer Funds Trust | 0,18% | 7 NS | 31 de Julho de 2026 | N-PORT |
| USMV · iShares Trust | 0,17% | 144.573 SH | 11 de Setembro de 2026 | Diário |
| EGLE · Global X Funds | 0,17% | 13 NS | 31 de Julho de 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,16% | 28.112 SH | 2 de Outubro de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,15% | 249.847 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,14% | 63.351 NS | 31 de Julho de 2026 | N-PORT |
| MGC · VANGUARD WORLD FUND | 0,14% | 52.742 SH | 19 de Agosto de 2026 | Diário |
| TOPC · iShares Trust | 0,14% | 159 SH | 11 de Setembro de 2026 | Diário |
| DIVB · iShares Trust | 0,13% | 9.546 SH | 11 de Setembro de 2026 | Diário |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,13% | 8.131 SH | 2 de Outubro de 2026 | Diário |
| IWL · iShares Trust | 0,13% | 10.119 SH | 11 de Setembro de 2026 | Diário |
| XVV · iShares Trust | 0,13% | 3.041 SH | 11 de Setembro de 2026 | Diário |
| VV · VANGUARD INDEX FUNDS | 0,12% | 308.954 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,12% | 59.034 SH | 19 de Agosto de 2026 | Diário |
| XYLD · Global X Funds | 0,12% | 13.766 NS | 31 de Julho de 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,12% | 9.915 NS | 31 de Julho de 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,11% | 1.207 NS | 31 de Julho de 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,11% | 13.352 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,11% | 13.613 NS | 31 de Julho de 2026 | N-PORT |
| XRMI · Global X Funds | 0,11% | 203 NS | 31 de Julho de 2026 | N-PORT |
| IVV · iShares Trust | 0,11% | 3.332.808 SH | 11 de Setembro de 2026 | Diário |
| BKLC · BNY Mellon ETF Trust | 0,11% | 21.844 NS | 31 de Julho de 2026 | N-PORT |
| XYLG · Global X Funds | 0,11% | 255 NS | 31 de Julho de 2026 | N-PORT |
| XTR · Global X Funds | 0,11% | 19 NS | 31 de Julho de 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 35.099 NS | 31 de Julho de 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,11% | 6.870.735 SH | 19 de Agosto de 2026 | Diário |
| TOV · EA Series Trust | 0,11% | 1.059 NS | 31 de Julho de 2026 | N-PORT |
| XCLR · Global X Funds | 0,11% | 14 NS | 31 de Julho de 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,11% | 4.302 NS | 31 de Julho de 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,11% | 1.573 SH | 2 de Outubro de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,11% | 80.995 NS | 31 de Julho de 2026 | N-PORT |
| ILCB · iShares Trust | 0,11% | 4.927 SH | 11 de Setembro de 2026 | Diário |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,11% | 45.808 SH | 2 de Outubro de 2026 | Diário |
| IYY · iShares Trust | 0,11% | 11.380 SH | 11 de Setembro de 2026 | Diário |
| SPUU · Direxion Shares ETF Trust | 0,11% | 998 NS | 31 de Julho de 2026 | N-PORT |
| IWB · iShares Trust | 0,10% | 180.235 SH | 11 de Setembro de 2026 | Diário |
| QDPL · Pacer Funds Trust | 0,10% | 6.372 NS | 31 de Julho de 2026 | N-PORT |
| ESG · FlexShares Trust | 0,10% | 480 NS | 31 de Julho de 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,10% | 21 NS | 31 de Julho de 2026 | N-PORT |
| ITOT · iShares Trust | 0,10% | 343.920 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,10% | 71.744 SH | 11 de Setembro de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,10% | 8.400.121 SH | 19 de Agosto de 2026 | Diário |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,10% | 43.269 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,10% | 21.990 SH | 19 de Agosto de 2026 | Diário |
| LGDX · Tidal Trust III | 0,10% | 497 NS | 31 de Julho de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,09% | 7.268 NS | 31 de Julho de 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,09% | 1.842 NS | 31 de Julho de 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,09% | 209 SH | 2 de Outubro de 2026 | Diário |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 2.691 SH | 2 de Outubro de 2026 | Diário |
| TOK · iShares Trust | 0,09% | 744 SH | 11 de Setembro de 2026 | Diário |
| SPXL · Direxion Shares ETF Trust | 0,09% | 20.684 NS | 31 de Julho de 2026 | N-PORT |
| URTH · iShares, Inc. | 0,08% | 23.813 SH | 11 de Setembro de 2026 | Diário |
| LRGF · iShares Trust | 0,08% | 10.058 SH | 11 de Setembro de 2026 | Diário |
| ACWI · iShares Trust | 0,07% | 83.068 SH | 11 de Setembro de 2026 | Diário |
| USCL · iShares Trust | 0,07% | 6.976 SH | 11 de Setembro de 2026 | Diário |
| NULC · Nushares ETF Trust | 0,06% | 152 NS | 31 de Julho de 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,06% | 219.986 SH | 19 de Agosto de 2026 | Diário |
| GLOF · iShares Trust | 0,02% | 150 SH | 11 de Setembro de 2026 | Diário |
| PEVC · Pacer Funds Trust | 0,01% | 1 NS | 31 de Julho de 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 109.800 | 2 de Outubro de 2026 | Diário |
| GTOS · Invesco Actively Managed Exchange-T… | 0,00% | 400 | 30 de Setembro de 2026 | Diário |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de Julho de 2026 | Diário |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de Julho de 2026 | Diário |
| VCEB · VANGUARD WORLD FUND | · | · | 30 de Julho de 2026 | Diário |
CI Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
Preço-alvo de 12 meses
24 analistas · 2026-10-02Alvo médio $342.29 +26,5%
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
Últimas notícias Notícias recentes mencionando esta empresa
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
Nenhum sinal aberto no momento — nenhum cartão está preenchido, e isso é honesto.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.